Condition
Patients with TNM 8th ed stage IB-IIC gastric adenocacinoma
Total Trials
1
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
7 treatments under study, led by Carboplatin
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Active Not Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Carboplatin1
- Oxaliplatin1
- Gastrectomy1
- Paclitaxel1
- Radiotherapy Of Gastric Cancer1
Active Sponsors
- The Netherlands Cancer Institute1
Top Investigators
The Netherlands Cancer Institute
Related Conditions
- Gastric Cancer1